As of Oct 02
| +0.1399 / +6.16%|
The 1 analysts offering 12-month price forecasts for Acura Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median estimate represents a +314.95% increase from the last price of 2.41.
The current consensus among 2 polled investment analysts is to Buy stock in Acura Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.